Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics and Anti-tumor Activity of HM95573
Clinical trial NCT02405065 · COMPLETED
Trial details
- NCT number
- NCT02405065
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-12
- Primary completion
- 2017-01-18
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.